StockpollyBeta
Get App
Delisting riskPopularity #3,805
AKAN · NASDAQ · Drug Manufacturers - Specialty & Generic

Akanda (AKAN)

Leases dark-fiber and telecommunications-tower infrastructure across Central Mexico.

$3.18
vs last close−0.05 (−1.47%)

In millions of USD, except per-share figures

In millionsQ2 FY20Jun 2020Q4 FY20Dec 2020Q2 FY21Jun 2021Q4 FY21Dec 2021Q2 FY22Jun 2022Q4 FY22Dec 2022Q2 FY23Jun 2023Q4 FY23Dec 2023Q2 FY24Jun 2024Q4 FY24Dec 2024Q2 FY25Jun 2025Q4 FY25Dec 2025
Revenue000003110000
Cost of revenue000175421001
Gross profit000−1−7−3−3−1000−1
110248332213
100248312213
Selling & marketing000024210000
General & administrative100225202210
Other expenses000000020100
Operating income−1−10−3−11−10−6−4−2−2−1−4
−11001510−22010−42
Interest income0000000——000
Interest expense1−10000000001
Other non-operating income0000−6−1000−100
Income before tax−200−34−9−6−26−2−1−1−46
Income tax expense000040000000
Net income from continuing operations−200−31−9−6−26−2−1−1−46
Discontinued operations00−2−4−40−3−250−11—
Other adjustments002010000000
Net income−410−3−3−9−6−26−3−1−1−45
EPS, basic−$195.48$32.40−$8.08−$161.40−$4,487.00−$13,084.00−$7,293.96−$1,876,264.00−$355.20−$49.20−$41.24−$655.12
EPS, diluted−$195.48$32.40−$8.08−$161.40−$4,487.00−$13,084.00−$7,293.96−$1,876,264.00−$355.20−$49.20−$41.24−$655.12
Weighted average shares, basic000000000000
Weighted average shares, diluted000000000000
EBITDA−1−10−3−4−7−4−2−2−1−1−3
Depreciation & amortization000022220000
EBIT−1−10−3−5−9−6−4−2−1−1−4